HIMS - Hims & Hers Health, Inc. Stock Price, Fair Value and News

14.58USD+0.54 (+3.85%)Market Closed

Market Summary

USD14.58+0.54

Market Closed

3.85%

HIMS Alerts

2 major insider sales recently.

Big jump in Revenue (Y/Y)
Big jump in Earnings (Y/Y)

HIMS Stock Price

View Fullscreen

HIMS RSI Chart

HIMS Valuation

Market Cap

3.1B

Price/Earnings (Trailing)

-1.3K

Price/Sales (Trailing)

3.24

EV/EBITDA

275.48

Price/Free Cashflow

34.64

HIMS Price/Sales (Trailing)

HIMS Profitability

Operating Margin

82.41%

EBT Margin

0.05%

Return on Equity

-0.68%

Return on Assets

-0.52%

Free Cashflow Yield

2.89%

HIMS Fundamentals

HIMS Revenue

Revenue (TTM)

959.4M

Rev. Growth (Yr)

45.81%

Rev. Growth (Qtr)

12.79%

HIMS Earnings

Earnings (TTM)

-2.4M

Earnings Growth (Yr)

210.54%

Earnings Growth (Qtr)

793.82%

Breaking Down HIMS Revenue

Last 7 days

18.6%

Last 30 days

17.5%

Last 90 days

45.4%

Trailing 12 Months

42.0%

How does HIMS drawdown profile look like?

HIMS Financial Health

Current Ratio

2.8

HIMS Investor Care

Shares Dilution (1Y)

3.05%

Diluted EPS (TTM)

-0.01

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	959.4M	0	0	0
2023	616.4M	710.7M	792.6M	872.0M
2022	320.9M	373.7M	444.4M	526.9M
2021	171.0M	195.8M	228.6M	271.9M
2020	99.1M	115.7M	132.2M	148.8M
2019	0	0	0	82.6M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Hims & Hers Health, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 03, 2024	baird melissa	sold	-136,826	11.6448	-11,750	chief operating officer
May 03, 2024	baird melissa	acquired	4,700	0.4	11,750	chief operating officer
May 02, 2024	baird melissa	sold	-141,923	12.0786	-11,750	chief operating officer
May 02, 2024	baird melissa	acquired	4,700	0.4	11,750	chief operating officer
May 01, 2024	dudum andrew	acquired	458,998	2.43	188,888	chief executive officer
May 01, 2024	baird melissa	acquired	4,700	0.4	11,750	chief operating officer
May 01, 2024	dudum andrew	sold	-2,367,890	12.5359	-188,888	chief executive officer
May 01, 2024	dudum andrew	sold	-1,832,420	12.686	-144,444	chief executive officer
May 01, 2024	baird melissa	sold	-148,122	12.6061	-11,750	chief operating officer
Apr 29, 2024	boughton soleil	sold	-31,437	12.56	-2,503	chief legal officer

Which funds bought or sold HIMS recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	COMERICA BANK	added	22.03	15,948	30,170	-%
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-3.95	872,458	2,175,620	-%
May 16, 2024	B. Riley Wealth Advisors, Inc.	sold off	-100	-154,860	-	-%
May 16, 2024	JANE STREET GROUP, LLC	reduced	-17.37	1,107,020	3,644,860	-%
May 15, 2024	ARMISTICE CAPITAL, LLC	new	-	554,785	554,785	0.01%
May 15, 2024	DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	reduced	-31.82	25,424	162,760	-%
May 15, 2024	MARSHALL WACE, LLP	added	7.04	40,356,000	87,254,400	0.13%
May 15, 2024	Man Group plc	reduced	-88.86	-695,921	167,076	-%
May 15, 2024	TWO SIGMA ADVISERS, LP	reduced	-73.93	-1,879,350	1,557,830	-%
May 15, 2024	AQR CAPITAL MANAGEMENT LLC	reduced	-50.57	-214,888	1,311,640	-%

Are Funds Buying or Selling HIMS?

Are funds buying HIMS calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own HIMS

No. of Funds

Unveiling Hims & Hers Health, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 29, 2024	institutional venture management xvi, llc	3.0%	6,222,558	SC 13D/A
Feb 14, 2024	abraham jack	4.6%	9,324,396	SC 13G/A
Feb 13, 2024	vanguard group inc	6.96%	14,173,285	SC 13G/A
Jan 31, 2024	blackrock inc.	5.3%	10,859,383	SC 13G
Jun 02, 2023	newview capital fund i, l.p.	2.0%	3,935,444	SC 13G/A
Mar 06, 2023	institutional venture management xvi, llc	3.9%	7,707,280	SC 13D/A
Mar 06, 2023	redpoint ventures vi, l.p.	3.8%	7,577,015	SC 13D/A
Mar 01, 2023	forerunner partners iii, l.p.	4.9%	9,756,893	SC 13D/A
Feb 14, 2023	newview capital fund i, l.p.	2.5%	5,053,698	SC 13G
Feb 13, 2023	abraham jack	6.0%	11,944,284	SC 13G/A

Recent SEC filings of Hims & Hers Health, Inc.

View All Filings

Date Filed	Form Type	Document
May 17, 2024	144	Notice of Insider Sale Intent
May 14, 2024	4	Insider Trading
May 14, 2024	4	Insider Trading
May 13, 2024	144	Notice of Insider Sale Intent
May 13, 2024	144	Notice of Insider Sale Intent
May 13, 2024	4	Insider Trading
May 09, 2024	144	Notice of Insider Sale Intent
May 09, 2024	4	Insider Trading
May 09, 2024	4	Insider Trading
May 06, 2024	10-Q	Quarterly Report

Peers (Alternatives to Hims & Hers Health, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
PG	395.7B	84.1B	6.80%	9.91%	26.16	4.71	3.82%	5.63%
CL	77.2B	19.8B	8.50%	18.11%	29.57	3.91	7.71%	63.39%
EL	48.4B	15.3B	-2.44%	-32.61%	72.94	3.15	-3.25%	-39.29%
CHD	26.0B	5.9B	2.80%	12.53%	33.35	4.38	8.05%	89.02%
CLX	16.8B	7.2B	-4.70%	-18.34%	70.19	2.34	0.53%	224.32%
COTY	9.2B	6.1B	0.19%	-6.00%	42.16	1.51	13.69%	13.11%
ELF	8.8B	890.1M	-4.70%	74.87%	67.98	9.88	79.24%	176.22%
MID-CAP
IPAR	4.0B	1.3B	0.70%	-6.53%	28.55	3	15.88%	-0.05%
NWL	3.4B	8.0B	17.03%	-8.34%	-11.41	0.42	-10.08%	-121.80%
HIMS	3.1B	959.4M	17.49%	41.97%	-1.3K	3.24	55.65%	96.05%
HELE	2.6B	2.0B	13.24%	10.40%	15.38	1.29	-3.26%	17.67%
SMALL-CAP
EPC	2.0B	2.3B	14.38%	-6.83%	16.18	0.88	1.98%	28.45%
ACU	144.4M	190.6M	-7.81%	61.36%	7.83	0.76	-2.98%	477.15%
GROV	55.5M	241.3M	0.66%	232.61%	-1.65	0.23	-20.28%	37.16%
UG	42.3M	11.6M	17.05%	-1.29%	15.37	3.65	1.70%	13.94%

Hims & Hers Health, Inc. News

Latest updates

Hims & Hers Health, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Revenue	12.8%	278,171,000	246,619,000	226,699,000	207,912,000	190,770,000	167,203,000	144,836,000	113,563,000	101,314,000	84,699,000	74,173,000	60,692,000	52,314,000	41,466,000	41,324,000	35,904,000	30,063,000	-
Cost Of Revenue	15.3%	49,076,000	42,561,000	39,391,000	37,754,000	37,345,000	34,866,000	30,383,000	26,387,000	26,558,000	22,601,000	19,301,000	13,415,000	12,067,000	9,574,000	10,047,000	10,242,000	9,444,000	-
Gross Profit	12.3%	229,095,000	204,058,000	187,308,000	170,158,000	153,425,000	132,337,000	114,453,000	87,176,000	74,756,000	62,098,000	54,872,000	47,277,000	40,247,000	31,892,000	31,277,000	25,662,000	20,619,000	-
Operating Expenses	7.2%	219,192,000	204,458,000	195,862,000	179,394,000	164,688,000	143,942,000	134,436,000	107,366,000	91,675,000	83,663,000	82,533,000	64,684,000	88,656,000	36,518,000	34,598,000	26,641,000	26,837,000	-
S&GA Expenses	-100.0%	-	32,319,000	35,907,000	31,144,000	30,513,000	27,568,000	26,246,000	22,567,000	21,811,000	5,786,500	25,190,000	36,740,000	61,698,000	-22,370,000	19,496,000	14,841,000	14,064,000	243,536
EBITDA Margin	182.3%	0.01	-0.01	-0.03	-0.05	-0.08	-0.11	-0.18	-0.21	-0.22	-0.39	-0.36	-0.36	-0.36	-0.11	-0.54	-0.62	-0.72	-0.86
Interest Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10,000	-
Income Taxes	34.1%	1,275,000	951,000	651,000	-13,000	386,000	-121,000	-16,000	12,000	94,000	-87,000	-3,173,000	34,000	90,000	24,000	31,000	37,000	35,000	-
Earnings Before Taxes	464.8%	12,403,000	2,196,000	-6,916,000	-7,170,000	-9,681,000	-11,028,000	-18,856,000	-19,667,000	-16,158,000	-31,248,000	-19,114,000	-9,119,000	-51,314,000	-5,205,000	-5,840,000	-944,000	-5,998,000	-
EBT Margin	102.2%	0.00	-0.02	-0.04	-0.07	-0.10	-0.12	-0.19	-0.23	-0.24	-0.41	-0.37	-0.37	-0.37	-0.12	-0.54	-0.62	-0.73	-0.87
Net Income	793.8%	11,128,000	1,245,000	-7,567,000	-7,157,000	-10,067,000	-10,907,000	-18,840,000	-19,679,000	-16,252,000	-31,161,000	-15,941,000	-9,153,000	-51,404,000	-5,229,000	-5,871,000	-981,000	-6,033,000	-6,419,439
Net Income Margin	90.9%	0.00	-0.03	-0.05	-0.07	-0.10	-0.12	-0.19	-0.22	-0.23	-0.40	-0.36	-0.37	-0.37	-0.12	-0.15	-0.11	-0.12	-0.87
Free Cashflow	17.5%	25,838,000	21,983,000	25,191,000	16,826,000	9,483,000	-6,719,000	5,985,000	-6,394,000	-19,403,000	-3,105,000	-15,960,000	601,000	-15,948,000	-269,000	3,136,000	-155,000	-5,191,000	-34,482

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																				(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2
Assets	1.6%	448	441	414	390	376	366	383	380	382	421	420	348	346	119	206	206	206	72.00	204	-
Current Assets	-1.3%	262	265	250	235	226	217	233	230	232	270	274	336	340	113	1.00	1.00	2.00	70.00	2.00	-
Cash Equivalents	9.8%	106	97.00	58.00	65.00	49.00	47.00	58.00	55.00	48.00	72.00	65.00	107	88.00	28.00	37.00	47.00	55.00	23.00	2.00	-
Inventory	32.8%	30.00	22.00	22.00	21.00	21.00	22.00	22.00	20.00	12.00	14.00	11.00	7.00	5.00	4.00	-	-	-	4.00	-	-
Goodwill	0%	111	111	111	111	111	111	111	111	111	111	111	3.00	-	-	-	-	-	-	-	-
Liabilities	6.7%	104	97.00	85.00	70.00	64.00	55.00	72.00	61.00	54.00	86.00	65.00	55.00	53.00	16.00	10.00	8.00	8.00	21.00	8.00	-
Current Liabilities	5.5%	93.00	88.00	83.00	67.00	56.00	48.00	67.00	56.00	49.00	79.00	52.00	27.00	20.00	15.00	3.00	1.00	1.00	21.00	1.00	1.00
Shareholder's Equity	0.1%	344	344	329	320	313	312	311	319	328	335	355	293	292	5.00	5.00	5.00	5.00	5.00	5.00	0.00
Retained Earnings	3.0%	-357	-368	-369	-361	-354	-344	-333	-314	-295	-278	-247	-231	-222	-171	0.00	2.00	2.00	-153	0.00	-0.02
Additional Paid-In Capital	-1.5%	702	712	698	682	668	657	645	634	623	614	603	525	515	24.00	5.00	3.00	3.00	13.00	5.00	0.00
Shares Outstanding	2.0%	213	209	209	208	207	205	205	204	203	187	200	192	153	35.00	35.00	35.00	35.00	35.00	-	-
Float	-	-	-	-	1,800	-	-	-	840	-	-	-	1,800	-	-	-	205	-	199	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																				(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2
Cashflow From Operations	17.5%	25,838	21,983	25,191	16,826	9,483	-6,719	5,985	-6,394	-19,403	-3,105	-15,960	601	-15,948	-269	3,136	-155	-5,191	-34.48	-207	-
Share Based Compensation	7.0%	19,032	17,791	17,277	16,845	14,167	12,350	10,979	10,632	8,856	11,952	11,869	9,160	34,230	1,088	1,414	1,925	1,404	-	-	-
Cashflow From Investing	-37.0%	13,042	20,695	-31,061	2,373	-4,113	6,003	-2,576	12,819	18,453	10,242	-25,922	22,736	-163,324	-8,082	-24,750	-14,102	7,233	-	-	-
Cashflow From Financing	-664.8%	-30,308	-3,963	-1,559	-2,541	-3,412	-10,459	-494	353	-22,527	-78.00	-484	-4,340	239,945	-707	12,367	5,747	30,335	-	-	-
Buy Backs	-	28,064	-	-	-	-	-	-	-	-	-22,027	-	125	21,902	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

HIMS Income Statement

2024-03-31

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue	$ 278,171	$ 190,770
Cost of revenue	49,076	37,345
Gross profit	229,095	153,425
Operating expenses:
Marketing	130,553	97,245
Operations and support	38,747	26,182
Technology and development	15,324	10,748
General and administrative	34,568	30,513
Total operating expenses	219,192	164,688
Income (loss) from operations	9,903	(11,263)
Other income (expense):
Change in fair value of liabilities	0	(295)
Other income, net	2,500	1,877
Total other income, net	2,500	1,582
Income (loss) before income taxes	12,403	(9,681)
Provision for income taxes	(1,275)	(386)
Net income (loss)	11,128	(10,067)
Other comprehensive (loss) income	(38)	166
Total comprehensive income (loss)	$ 11,090	$ (9,901)
Net income (loss) per share attributable to common stockholders:
Basic (in dollars per share)	$ 0.05	$ (0.05)
Diluted (in dollars per share)	$ 0.05	$ (0.05)
Weighted average shares outstanding:
Basic (in shares)	213,452,092	207,140,298
Diluted (in shares)	229,364,585	207,140,298

HIMS Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 105,237	$ 96,663
Short-term investments	98,355	124,318
Inventory	29,826	22,464
Prepaid expenses and other current assets	28,316	21,608
Total current assets	261,734	265,053
Restricted cash	856	856
Goodwill	110,881	110,881
Property, equipment, and software, net	45,212	36,143
Intangible assets, net	17,863	18,574
Operating lease right-of-use assets	11,422	9,588
Other long-term assets	138	91
Total assets	448,106	441,186
Current liabilities:
Accounts payable	43,919	43,070
Accrued liabilities	26,714	28,972
Deferred revenue	13,735	7,733
Earn-out payable	7,412	7,412
Operating lease liabilities	1,544	1,281
Total current liabilities	93,324	88,468
Operating lease liabilities	10,279	8,667
Other long-term liabilities	21	22
Total liabilities	103,624	97,157
Commitments and contingencies
Stockholders' equity:
Common stock – Class A shares, par value $0.0001, 2,750,000,000 shares authorized and 206,033,630 and 205,104,120 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively; Class V shares, par value $0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of March 31, 2024 and December 31, 2023	21	21
Additional paid-in capital	701,670	712,307
Accumulated other comprehensive loss	(162)	(124)
Accumulated deficit	(357,047)	(368,175)
Total stockholders' equity	344,482	344,029
Total liabilities and stockholders' equity	$ 448,106	$ 441,186

About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

CEO	Mr. Andrew Dudum
WEBSITE	forhims.com
INDUSTRY	Household Products
EMPLOYEES	651

Hims & Hers Health, Inc. Frequently Asked Questions

What is the ticker symbol for Hims & Hers Health, Inc.? What does HIMS stand for in stocks?

HIMS is the stock ticker symbol of Hims & Hers Health, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Hims & Hers Health, Inc. (HIMS)?

As of Fri May 17 2024, market cap of Hims & Hers Health, Inc. is 3.11 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HIMS stock?

You can check HIMS's fair value in chart for subscribers.

What is the fair value of HIMS stock?

You can check HIMS's fair value in chart for subscribers. The fair value of Hims & Hers Health, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Hims & Hers Health, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for HIMS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Hims & Hers Health, Inc. a good stock to buy?

The fair value guage provides a quick view whether HIMS is over valued or under valued. Whether Hims & Hers Health, Inc. is cheap or expensive depends on the assumptions which impact Hims & Hers Health, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HIMS.

What is Hims & Hers Health, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, HIMS's PE ratio (Price to Earnings) is -1323.75 and Price to Sales (PS) ratio is 3.24. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HIMS PE ratio will change depending on the future growth rate expectations of investors.